Product label reads in part as "WHITE VEIN ADVANCED ALKALOIDS CHEWABLE TABLETS 15mg…
Shaman Botanicals, LLC recalled this product and the FDA reported the enforcement action on 25 March 2026 as Class I. The recall was initiated by the firm. A sample of the product had the active ingredient in a quantity greater than the labeled specification.

The record
Every field below is published by the FDA in the openFDA food enforcement database. Check the FDA notice before acting on any recall: this page is a reading of the public record, not a substitute for it.
- Product
- Product label reads in part as "WHITE VEIN ADVANCED ALKALOIDS CHEWABLE TABLETS 15mg 7-Hydroxymitragynine per container (7.5mg 7-OH per serving) LEMON DIETARY SUPPLEMENT Net Wt. 0.02 oz 2 TABLETS Supplement Facts 7-hydroxymitragynine 7.5 mg MANUFACTURED BY: Konig Products, LLC 30 N Gould Street, Suite R, Sheridan, WY 82801"; Packaging: Sealed silver metallic bag with a front and back sticker for the labels; Product label reads in part as "WHITE VEIN ADVANCED ALKALOIDS CHEWABLE TABLETS 150mg total 7-Hydroxymitragynine per container (10 Packets x 2 Tablets Each) 7.5mg 7-OH per tablet/serving, LEMON DIETARY SUPPLEMENT Net Wt. 0.17 oz 10 PACKETS 2 TABLETS EACH Supplement Facts 7-hydroxymitragynine 7.5 mg MANUFACTURED BY: Konig Products, LLC 30 N Gould Street, Suite R, Sheridan, WY 82801"; Packaging: Sealed black flexible plastic bag with multi color sticker label on front and back UPC 810057763724
- UPC
- 810057763724
- Reason for recall
- A sample of the product had the active ingredient in a quantity greater than the labeled specification.
- Recalling firm
- Shaman Botanicals, LLC
- Firm location
- North Kansas City, Missouri, United States
- Classification
- Class I
- Status
- Ongoing
- Recall number
- H-1107-2026
- Quantity
- 2 pack: 1281 units; 20-count: 14,491 units
- Distribution
- Firm has provided the following information: 14 wholesalers, 108 Distributors, 46 Company-owned stores, 2202 online customers
- Initiated
- 13 February 2026
- Reported by FDA
- 25 March 2026
- Firm notified by
- Press Release
- Product codes
- B#AAW.501.3; all expiration dates
Reading this record
Five things about this record are not in the record itself, and each one changes how it should be read.
- Class I means the FDA judged a reasonable probability that the product would cause serious health consequences or death. The class is assigned by an agency health hazard evaluation under 21 CFR 7.41, not by the firm.
- The firm started this recall itself. Most FDA food recalls are voluntary, and a recall is a food safety plan working rather than failing. The circumstances in which the agency asks for one instead are set out in 21 CFR 7.45.
- This is one of 2 records covering the same recall event. The FDA opens one enforcement record per product code, so a recall of a product line appears here many times. Counting these records as 2 separate recalls, which almost every published figure does, overstates it by a factor of 2. All 2 of them are listed on this page.
- This recall has no termination date on the record, so as published it had not been terminated under 21 CFR 7.55.
- The FDA published the enforcement report 6 weeks after the firm began the recall.
- Dietary supplements are regulated under their own good manufacturing practice rule, 21 CFR part 111, and they are the only food category where the dominant recall reason is an ingredient that was never declared because it is a pharmaceutical.
Filed under dietary supplements. A product can sit in more than one.
Every product in this recall
The FDA opened 2 enforcement records for this one recall, one per product code. This page carries all of them; the 1 below each have their own page with that product’s lot codes and distribution, and search engines are pointed here for the recall as a whole.
| Reported | Product | Firm | Reason | Class |
|---|---|---|---|---|
| 2026-03-25 | Product label reads in part as "WHITE VEIN ADVANCED ALKALOIDS CHEWABLE TABLETS 225mg 7-Hydroxymitragynine per container (7.5mg 7-OH per serving) LEMON DIETARY SUPPLEMENT Net Wt. 0.25 oz 30 TABLETS Supplement Facts 7-hydroxymitragynine 7.5 mg MANUFACTURED BY: Konig Products, LLC 30 N Gould Street, Suite R, Sheridan, WY 82801"; Packaging: White child-resistant plastic bottle with sticker label applied UPC 810057763779 (sometimes proceeded by 00) | Shaman Botanicals, LLC | A sample of the product revealed the active ingredient is in a quantity greater than the labeled specification. | Class I |
Other dietary supplements recalls
These are the closest records in the corpus: the same kind of food. Unlike the firm’s own records below, they come from different companies, which is what makes them a pattern rather than a history.
Other records from Shaman Botanicals, LLC
The FDA opens one enforcement record per product code, so several of these are frequently one recall event.
| Reported | Product | Firm | Reason | Class |
|---|---|---|---|---|
| 2026-03-25 | Product label reads in part as "WHITE VEIN ADVANCED ALKALOIDS CHEWABLE TABLETS 225mg 7-Hydroxymitragynine per container (7.5mg 7-OH per serving) LEMON DIETARY SUPPLEMENT Net Wt. 0.25 oz 30 TABLETS Supplement Facts 7-hydroxymitragynine 7.5 mg MANUFACTURED BY: Konig Products, LLC 30 N Gould Street, Suite R, Sheridan, WY 82801"; Packaging: White child-resistant plastic bottle with sticker label applied UPC 810057763779 (sometimes proceeded by 00) | Shaman Botanicals, LLC | A sample of the product revealed the active ingredient is in a quantity greater than the labeled specification. | Class I |
All 2026 recalls · All FDA food recall data
Behind every recall is a clause somebody has to produce evidence for at their next audit. Krolda maps supplier documents to the clause they satisfy in FSSC 22000, IFS Food and 21 CFR 117, and routes the corrective action when the evidence is missing.
Early accessRecall records come from the openFDA food enforcement API, published by the U.S. Food and Drug Administration in the public domain. Krolda adds the hazard classification and the clause mapping; neither is an FDA determination. Always check the FDA notice before acting on a recall.